3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
4
Oropharyngeal Neoplasms
3
Laryngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Mouth Neoplasms
2
Mesothelioma
2
Hypopharyngeal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Astrocytoma
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
PSA Level Greater Than Two
1
Oligodendroglioma
1
Nasopharyngeal Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma, Follicular
1
Lymphoid Interstitial Pneumonia
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Carcinoma, Squamous Cell
1
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
Vincristine
3
Doxorubicin
3
Dactinomycin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Radiotherapy, Conformal
2
Cyclophosphamide
2
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
cabozantinib
1
atezolizumab
1
Vemurafenib
1
Temozolomide
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Radiotherapy, Intensity-Modulated
×
30 days
×
Clear all
No trials found.